Cargando…

IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination

Vaccination induces immunostimulatory signals that are often accompanied by regulatory mechanisms such as IL-10, which control T-cell activation and inhibit vaccine-dependent antitumor therapeutic effect. Here we characterized IL-10-producing cells in different tumor models treated with therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Llopiz, Diana, Ruiz, Marta, Infante, Stefany, Villanueva, Lorea, Silva, Leyre, Hervas-Stubbs, Sandra, Alignani, Diego, Guruceaga, Elizabeth, Lasarte, Juan J, Sarobe, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356831/ https://www.ncbi.nlm.nih.gov/pubmed/27926522 http://dx.doi.org/10.18632/oncotarget.13736

Ejemplares similares

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
por: Repáraz, David, et al.
Publicado: (2022)

Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10
por: Llopiz, Diana, et al.
Publicado: (2018)

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma
por: Silva, Leyre, et al.
Publicado: (2020)

Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection
por: Zabaleta, Aintzane, et al.
Publicado: (2015)

Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor
por: Lozano, Teresa, et al.
Publicado: (2017)

Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
por: Repáraz, David, et al.
Publicado: (2022)

Helper cell-independent antitumor activity of potent CD8(+) T cell epitope peptide vaccines is dependent upon CD40L
por: Llopiz, Diana, et al.
Publicado: (2013)

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
por: Aparicio, Belén, et al.
Publicado: (2022)

A Fusion Protein between Streptavidin and the Endogenous TLR4 Ligand EDA Targets Biotinylated Antigens to Dendritic Cells and Induces T Cell Responses In Vivo
por: Arribillaga, Laura, et al.
Publicado: (2013)

Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens
por: Arribillaga, Laura, et al.
Publicado: (2020)

Advances in immunotherapy for hepatocellular carcinoma
por: Sangro, Bruno, et al.
Publicado: (2021)

Genetic Modification of CD8(+) T Cells to Express EGFR: Potential Application for Adoptive T Cell Therapies
por: Lozano, Teresa, et al.
Publicado: (2019)

Mutated trimeric RBD vaccines: a platform against variants of concern
por: Aparicio, Belén, et al.
Publicado: (2023)

Immunomodulatory Properties of Carvone Inhalation and Its Effects on Contextual Fear Memory in Mice
por: Lasarte-Cia, Aritz, et al.
Publicado: (2018)

Intracellular role of IL-6 in mesenchymal stromal cell immunosuppression and proliferation
por: Dorronsoro, Akaitz, et al.
Publicado: (2020)

Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
por: Aparicio, Belén, et al.
Publicado: (2023)

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
por: Aparicio, Belén, et al.
Publicado: (2023)

Intratumoral electroporation of a self-amplifying RNA expressing IL-12 induces antitumor effects in mouse models of cancer
por: Silva-Pilipich, Noelia, et al.
Publicado: (2022)

Neoantigens as potential vaccines in hepatocellular carcinoma
por: Repáraz, David, et al.
Publicado: (2022)

Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy
por: Navarro, Flor, et al.
Publicado: (2022)

ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity
por: Soldevilla, Mario Martínez, et al.
Publicado: (2019)

Midbrain microglia mediate a specific immunosuppressive response under inflammatory conditions
por: Abellanas, Miguel Angel, et al.
Publicado: (2019)

Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses
por: Aparicio, Belén, et al.
Publicado: (2021)

Red-Light-Activatable AND-Gated Antitumor Immunosuppressant
por: Zhou, Ziqi, et al.
Publicado: (2023)

Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naïve T-cell priming
por: Merrick, A, et al.
Publicado: (2005)

The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1(+) tumour-infiltrating lymphocytes
por: Salas-Benito, Diego, et al.
Publicado: (2021)

Role of dendritic cells in the regulation of antitumor immunity
por: Wathelet, Nathalie, et al.
Publicado: (2013)

Epigenetic changes in dendritic cells in sepsis-associated immunosuppression
por: Molinaro, Raphael, et al.
Publicado: (2013)

Co-transfection of dendritic cells with AFP and IL-2 genes enhances the induction of tumor antigen-specific antitumor immunity
por: YANG, JING-YUE, et al.
Publicado: (2012)

Immunosuppression induced by immature dendritic cells is mediated by TGF-β/IL-10 double-positive CD4(+) regulatory T cells
por: Cools, N, et al.
Publicado: (2008)

The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
por: Gonzalez-Sanchez, Ester, et al.
Publicado: (2021)

The Beneficial Effect of IL-12 and IL-18 Transduced Dendritic Cells Stimulated with Tumor Antigens on Generation of an Antitumor Response in a Mouse Colon Carcinoma Model
por: Mierzejewska, Jagoda, et al.
Publicado: (2022)

Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
por: Schaaf, Marco B., et al.
Publicado: (2018)

Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity
por: Van den Bergh, Johan, et al.
Publicado: (2015)

CD137 Costimulation Enhances the Antitumor Activity of Vγ9Vδ2-T Cells in IL-10-Mediated Immunosuppressive Tumor Microenvironment
por: Pei, Yujun, et al.
Publicado: (2022)

Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations
por: Ye, Jun, et al.
Publicado: (2021)

Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor Vaccination
por: Benencia, Fabian, et al.
Publicado: (2012)

λ-Carrageenan improves the antitumor effect of dendritic cellbased vaccine
por: Li, Jinyao, et al.
Publicado: (2017)

Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells
por: Sevilla, Noemí, et al.
Publicado: (2000)

Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes
por: Salimu, Josephine, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nqedn77eho0m1sofb408i1m3ao